CiVi Biopharma Announces Appointment of Shalom Jacobovitz as Chief Executive Officer Mr. Jacobovitz Previously Served as Chief Executive Officer of American College of Cardiology and President of Actelion Pharmaceuticals Ltd. CiVi Expects to Enter Clinic with Lead PCSK9 Inhibitor in...